We’re delighted to share that Remediiate has been featured in NovAzure’s overview of innovators in the European CCUS market, published in October 2025 by the net zero advisory and investment firm.

The article maps the most significant players across the European carbon capture, utilisation and storage landscape — from mineralisation and Direct Air Capture to ocean-based solutions and alternative fuels. Remediiate is highlighted within the Biological CCUS category, recognised for using microalgae in photobioreactors to convert CO₂ into high-value animal feed, and placed alongside globally recognised names including Climeworks, Shell, Neste, and Equinor.

🔗 Find out more here: https://novazure.com/an-overview-of-innovators-in-the-ccus-market-in-europe/

Being independently identified by a leading net zero advisory firm as one of Europe’s most significant CCUS innovators is a powerful endorsement of where Remediiate sits in the market. As the European CCUS landscape continues to attract record investment and policy support, Remediiate is well positioned to play a central role in shaping what comes next.